Cited by 91Cutaneous Melanoma Detection and Managementmelanin and skin pigmentationGlobal Cancer Incidence and Screening

Factors related to the presentation of thin and thick nodular melanoma from a population‐based cancer registry in Queensland Australia

Open access
Geller, Alan C., Elwood, Mark, Swetter, Susan M., Brooks, Daniel R., Aitken, Joanne, Youl, Philippa H., Demierre, Marie‐France, Baade, Peter D.·2009·Cancer

Abstract

BACKGROUND: Worldwide, the incidence of thick melanoma has not declined, and the nodular melanoma (NM) subtype accounts for nearly 40% of newly diagnosed thick melanoma. To assess differences between patients with thin (≤2.00 mm) and thick (≥2.01 mm) nodular melanoma, the authors evaluated factors such as demographics, melanoma detection patterns, tumor visibility, and physician screening for NM alone and compared clinical presentation and anatomic location of NM with superficial spreading melanoma (SSM). METHODS: The authors used data from a large population‐based study of Queensland (Australia) residents diagnosed with melanoma. Queensland residents aged 20 to 75 years with histologically confirmed first primary invasive cutaneous melanoma were eligible for the study, and all questionnaires were conducted by telephone (response rate, 77.9%). RESULTS: During this 4‐year period, 369 patients with nodular melanoma were interviewed, of whom 56.7% were diagnosed with tumors ≤2.00 mm. Men, older individuals, and those who had not been screened by a physician in the past 3 years were more likely to have nodular tumors of greater thickness. Thickest nodular melanoma (4 mm+) was also most common in persons who had not been screened by a physician within the past 3 years (odds ratio, 3.75; 95% confidence interval, 1.47‐9.59). Forty‐six percent of patients with thin nodular melanoma (≤2.00 mm) reported a change in color, compared with 64% of patients with thin SSM and 26% of patients with thick nodular melanoma (>2.00 mm). CONCLUSIONS: Awareness of factors related to earlier detection of potentially fatal nodular melanomas, including the benefits of a physician examination, should be useful in enhancing public and professional education strategies. Particular awareness of clinical warning signs associated with thin nodular melanoma should allow for more prompt diagnosis and treatment of this subtype. Cancer 2009. © 2009 American Cancer Society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.24162

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other factors associated with delayed diagnosis are related to the opportunity to consult a dermatologist rather than a general practitioner.

    “Other factors are related to the opportunity to consult a dermatologist rather than a general practitioner [4,13].”

    From Use of Smartphones for Early Detection of Melanoma: Systematic Review (2018) · cites this paper as [4]

    The Conclusions (page unavailable) report that thick nodular melanoma was more common among people without a physician skin examination in the preceding three years and among those who detected their own lesions. That supports an association with physician examination, but the paper does not compare opportunities to consult a dermatologist rather than a general practitioner. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Numerous factors associated with a delayed diagnosis of melanoma are patient-related.

    “Numerous factors associated with a delayed diagnosis are patient-related [4-12].”

    From Use of Smartphones for Early Detection of Melanoma: Systematic Review (2018) · cites this paper as [4]

    The Conclusions (page not provided) associate thicker nodular melanoma with patient characteristics, including male sex, advanced age, and self-detection rather than physician detection. These findings support a patient-related component to later detection, but the paper does not establish that those factors caused a delay in diagnosis or measure diagnostic delay directly. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. Krige JE, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA. Delay in the diagnosis of cutaneous melanoma: a prospective study in 250 patients. Cancer 1991;68:2064-2068.
  2. Brady MS, Oliveria SA, Christos PJ, et al. Patterns of detection in patients with cutaneous melanoma: implications for secondary prevention. Cancer 2000;89:342- 7.
  3. Richard MA, Grob JJ, Avril MR, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer. 2000;89:280-285.
  4. Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Johnson TM. Thin primary cutaneous melanoma: associated detection patterns, lesion characteristics, and patient characteristics. Cancer 2002;95:1562-1568.
  5. Institute of Medicine. Extending Medicare coverage for prevention and other services. Washington DC: National Academy Press, 2000.
  6. Elder D, Viros A, Fridlyand J, Bauer J, et al. Histomorphological signature of mutation status in melanoma. In: American Association for Cancer Research Annual Meeting: Proceedings; 2007 Apr 14-18; Los Angeles, CA. Philadelphia (PA):AACR:2007. Abstract nr 154.

Cited by

Sorted by citations

Authors
Geller, A. C., Elwood, M., Swetter, S. M., Brooks, D. R., Aitken, J., Youl, P. H., Demierre, M., & Baade, P. D.
Affiliations
  • Harvard University (US)
  • BC Cancer Agency (CA)
  • VA Palo Alto Health Care System (US)
  • Boston University (US)
  • The University of Queensland (AU)
  • Cancer Council Queensland (AU)
  • Queensland University of Technology (AU)
Corresponding author
Geller, Alan C.
Venue
Cancer
Publisher
Wiley
Published
2009-02-02
Volume
115
Issue
6
Pages
1318-1327
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1519927461
Cited by
91
References
29
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 7 · 2014: 15 · 2013: 7 · 2012: 8
FWCI
4.17
Type
journal article
Language
en
Open access
Locations
  • Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion)
  • Faculty of Health
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
nodular melanoma, thin melanoma, thick melanoma, melanoma thickness, superficial spreading melanoma, melanoma detection, clinical warning signs, tumor visibility, melanoma risk factors, Queensland
MeSH terms
Adult, Aged, Female, Health Surveys, Humans, Male, Melanoma, Middle Aged, Physical Examination, Queensland, Surveys and Questionnaires, Registries, Skin Neoplasms, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review